Anticoagulation in the cardiac patient: A concise review

Elise A. Larson, David M. German, Joseph Shatzel, Thomas Deloughery

    Research output: Contribution to journalArticle

    Abstract

    Anticoagulation has multiple roles in the treatment of cardiovascular disease, including in management of acute myocardial infarction, during percutaneous coronary intervention, as stroke prophylaxis in patients with atrial arrhythmias, and in patients with mechanical heart valves. Clinical anticoagulation choices in the aforementioned diseases vary widely, due to conflicting data to support established agents and the rapid evolution of evidence-based practice that parallels more widespread use of novel oral anticoagulants. This review concisely summarizes evidence-based guidelines for anticoagulant use in cardiovascular disease, and highlights new data specific to direct oral anticoagulants.

    Original languageEnglish (US)
    JournalEuropean Journal of Haematology
    DOIs
    StateAccepted/In press - Jan 1 2018

    Fingerprint

    Anticoagulants
    Cardiovascular Diseases
    Evidence-Based Practice
    Heart Valves
    Percutaneous Coronary Intervention
    Cardiac Arrhythmias
    Stroke
    Myocardial Infarction
    Guidelines
    Therapeutics

    Keywords

    • anticoagulation
    • atrial fibrillation
    • cardiovascular disease
    • direct oral anticoagulants
    • novel oral anticoagulants
    • nste-acs

    ASJC Scopus subject areas

    • Hematology

    Cite this

    Anticoagulation in the cardiac patient : A concise review. / Larson, Elise A.; German, David M.; Shatzel, Joseph; Deloughery, Thomas.

    In: European Journal of Haematology, 01.01.2018.

    Research output: Contribution to journalArticle

    @article{53e376601468419e8443ba208f5de71c,
    title = "Anticoagulation in the cardiac patient: A concise review",
    abstract = "Anticoagulation has multiple roles in the treatment of cardiovascular disease, including in management of acute myocardial infarction, during percutaneous coronary intervention, as stroke prophylaxis in patients with atrial arrhythmias, and in patients with mechanical heart valves. Clinical anticoagulation choices in the aforementioned diseases vary widely, due to conflicting data to support established agents and the rapid evolution of evidence-based practice that parallels more widespread use of novel oral anticoagulants. This review concisely summarizes evidence-based guidelines for anticoagulant use in cardiovascular disease, and highlights new data specific to direct oral anticoagulants.",
    keywords = "anticoagulation, atrial fibrillation, cardiovascular disease, direct oral anticoagulants, novel oral anticoagulants, nste-acs",
    author = "Larson, {Elise A.} and German, {David M.} and Joseph Shatzel and Thomas Deloughery",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1111/ejh.13171",
    language = "English (US)",
    journal = "European Journal of Haematology",
    issn = "0902-4441",
    publisher = "Wiley-Blackwell",

    }

    TY - JOUR

    T1 - Anticoagulation in the cardiac patient

    T2 - A concise review

    AU - Larson, Elise A.

    AU - German, David M.

    AU - Shatzel, Joseph

    AU - Deloughery, Thomas

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - Anticoagulation has multiple roles in the treatment of cardiovascular disease, including in management of acute myocardial infarction, during percutaneous coronary intervention, as stroke prophylaxis in patients with atrial arrhythmias, and in patients with mechanical heart valves. Clinical anticoagulation choices in the aforementioned diseases vary widely, due to conflicting data to support established agents and the rapid evolution of evidence-based practice that parallels more widespread use of novel oral anticoagulants. This review concisely summarizes evidence-based guidelines for anticoagulant use in cardiovascular disease, and highlights new data specific to direct oral anticoagulants.

    AB - Anticoagulation has multiple roles in the treatment of cardiovascular disease, including in management of acute myocardial infarction, during percutaneous coronary intervention, as stroke prophylaxis in patients with atrial arrhythmias, and in patients with mechanical heart valves. Clinical anticoagulation choices in the aforementioned diseases vary widely, due to conflicting data to support established agents and the rapid evolution of evidence-based practice that parallels more widespread use of novel oral anticoagulants. This review concisely summarizes evidence-based guidelines for anticoagulant use in cardiovascular disease, and highlights new data specific to direct oral anticoagulants.

    KW - anticoagulation

    KW - atrial fibrillation

    KW - cardiovascular disease

    KW - direct oral anticoagulants

    KW - novel oral anticoagulants

    KW - nste-acs

    UR - http://www.scopus.com/inward/record.url?scp=85056663574&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85056663574&partnerID=8YFLogxK

    U2 - 10.1111/ejh.13171

    DO - 10.1111/ejh.13171

    M3 - Article

    C2 - 30203452

    AN - SCOPUS:85056663574

    JO - European Journal of Haematology

    JF - European Journal of Haematology

    SN - 0902-4441

    ER -